Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with persistent or long-standing persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) — (confirm with trial site which phase applies to you)
- You have persistent atrial fibrillation and have never had a catheter ablation procedure for it before (for one specific phase of the trial)
- You are between 18 and 80 years old
- You have symptoms related to your atrial fibrillation and your doctor has already recommended a standard ablation procedure to treat it
- You are able to sign a consent form agreeing to take part
- You are able and willing to attend all required study visits and complete all study procedures
Who may not be able to join:
- You had a heart attack in the last 3 months
- You had any heart procedure or surgery (including heart ablation or a procedure on your arteries) in the last 3 months
- A blood clot was found in your body on a scan in the last 3 months
- You had open heart surgery (including bypass surgery) in the last 6 months
- You had a stroke in the last 6 months
- You have been told you have the most severe level of heart failure (classified as NYHA Class IV)
- Your heart's pumping ability is very low (less than 30% efficiency)
- The upper left chamber of your heart is larger than 55mm (confirm with trial site which phase this applies to)
- You have had a procedure on the arteries in your neck (stenting or endarterectomy)
- You have had a procedure to close a hole in your heart or seal off part of your heart
- You have a permanent pacemaker, defibrillator, or similar implanted heart device (a small implanted heart monitor called a loop recorder is allowed)
- There is a blood clot, tumour, or other blockage inside your heart or blood vessels that would make the procedure unsafe
- You have unstable chest pain (unstable angina)
- You have had surgery or a repair on your mitral or tricuspid heart valves, or have an artificial heart valve
- You have moderate to severe narrowing of the mitral valve or another serious valve problem
- You have any condition that affects your blood's ability to clot or stop bleeding
- You cannot safely take blood-thinning medication
- Your atrial fibrillation is caused by something temporary or treatable, such as an electrolyte imbalance, recent heavy alcohol use, or another non-heart-related cause
- Your Body Mass Index (BMI) is over 40 (a measure of body weight relative to height)
- You have a serious lung disease, high blood pressure in the lungs, or any ongoing breathing condition
- Your kidneys have failed and you require dialysis or a kidney transplant
- You have a current acute illness, active infection, or blood poisoning (sepsis)
- You have an active dependency on alcohol or drugs
- You have a specific type of thickened heart muscle disease (hypertrophic cardiomyopathy) or a protein build-up condition affecting the heart (cardiac amyloidosis)
- You have heart failure caused by a lung condition (cor pulmonale)
- There is any other reason that might make the procedure take significantly longer than expected (confirm with trial site)
- You are currently pregnant, breastfeeding, or could become pregnant and are not using a reliable method of contraception or abstinence
- You are considered to be part of a vulnerable group (confirm with trial site)
- You are not expected to live for more than one year
- You work for the hospital running the trial or for the company sponsoring it
- You are currently taking part in another study that could interfere with this one
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sarah Kalil, CoreMap Inc.
Phone: 6178723908
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Phases 1 and Phase 2 Primary Endpoint:; Phase 2 and Phase 3 Primary Effectiveness Endpoint:
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.